Immunosuppressive therapy and oral anticoagulation in kidney transplant recipients: Direct oral anticoagulants versus vitamin-k antagonists
European Journal of Internal Medicine · 2024-01 · 119 · 71-77
DOI: 10.1016/j.ejim.2023.08.003 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Internal Medicine, 2024-01. Verfasst von Francesco Santoro und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical sciences, University of Foggia, Italy;. Electronic address: dr.francesco.santoro.it@gmail.com. Hauptthemen laut MEDLINE: Kidney Transplantation, Cyclosporins, Atrial Fibrillation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: direct oral anticoagulants (DOACs) are an alternative to conventional antagonist of vitamin-K (AVK). However, immune suppressive drugs (ISDs) may interfere with DOACs pharmacokinetic. AIM OF THIS STUDY: evaluate safety and efficacy profile of DOACs compared to AVK in kidney transplant recipients (KTRs) treated with ISDs. METHODS: a multi-center study from 4 Italian University hospitals enrolling consecutive KTRs on DOACs or AVK was carried out. Sixty-six patients on DOACs were compared with fifty patients on AVK with similar clinical features. Serial evaluation of renal function and serum levels of ISDs during 18 months follow-up (FU) was performed. RESULTS: Mean age of DOACs patients was 67±9 and mean eGFR was 58,3± 30,4mL/min/1.73m2. ISDs included tacrolimus (n=47, 71%), cyclosporin (n=13, 20%), everolimus (n=10, 7%) and sirolimus (n=4, 6%). After 14 days of DOACs therapy initiation there was a slight increase of serum levels of tacrolimus (+0.19±0.67 p=0.80) and cyclosporine (+0.12±0.25 p=0.94) not statistically significant. Levels of Tacrolimus and cyclosporin were stable at serial evaluation during 18-months follow-up. There were no thromboembolic events among patients treated with DOACs or AVK and no differences in term of major bleeding (6% vs 4% p=0.69), at long-term follow-up. There was no difference in term of eGFR decline from start therapy to 18 months FU between DOACs vs AVK therapy (-3.9±1 vs -3.8±2 p=0.82). CONCLUSION: DOACs have similar safety and efficacy than AVK among KTRs treated with ISDs. However, careful evaluation of potential drug interaction and ISDs serum levels is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical and Surgical sciences, University of Foggia, Italy;. Electronic address: dr.francesco.santoro.it@gmail.com.
- Nephrology, Dialysis and Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area - (DiMePRe-J), University of Bari "A. Moro", Bari, Italy;. Electronic address: lisa89.casanova@gmail.com.
- Nephrology, Dialysis and Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area - (DiMePRe-J), University of Bari "A. Moro", Bari, Italy;. Electronic address: simonasimone1976@gmail.com.
- Department of Clinical Sciences and Community Health, University of Milan, Italy;; Unit of Nephrology Dialysis and Renal Transplantation, IRCCS Cà Granda Ospedale Maggiore Policlinico Milan, Italy. Electronic address: c…
- Department of Clinical Sciences and Community Health, University of Milan, Italy;; Unit of Nephrology Dialysis and Renal Transplantation, IRCCS Cà Granda Ospedale Maggiore Policlinico Milan, Italy. Electronic address: a…
- Department of Translational Medicine and Surgery, University Cattolica Sacro Cuore, Rome, Italy;. Electronic address: andrea.dellostrologo@gmail.com.
Zitieren
APA
Santoro, F., Casanova, A., Simone, S., Alfieri, C., Falcone, A., Dello Strologo, A., Grandinetti, V., Busutti, M., Comai, G., Marvulli, T. M., Zippo, M. G., Castellano, G., La Manna, G., Gesualdo, L., Giuseppe, G., & Pesce, F. (2024). Immunosuppressive therapy and oral anticoagulation in kidney transplant recipients: Direct oral anticoagulants versus vitamin-k antagonists. European Journal of Internal Medicine, 119, 71-77. https://doi.org/10.1016/j.ejim.2023.08.003
Vancouver
Santoro F, Casanova A, Simone S, Alfieri C, Falcone A, Dello Strologo A, et al. Immunosuppressive therapy and oral anticoagulation in kidney transplant recipients: Direct oral anticoagulants versus vitamin-k antagonists. European Journal of Internal Medicine. 2024;119:71-77. doi:10.1016/j.ejim.2023.08.003
BibTeX
@article{Santoro2024,
author = {Santoro, Francesco and Casanova, Annalisa and Simone, Simona and Alfieri, Carlo and Falcone, Adele and Dello Strologo, Andrea and Grandinetti, Valeria and Busutti, Marco and Comai, Giorgia and Marvulli, Tommaso Maria and Zippo, Maria Grazia and Castellano, Giuseppe and La Manna, Gaetano and Gesualdo, Loreto and Giuseppe, Grandaliano and Pesce, Francesco},
title = {Immunosuppressive therapy and oral anticoagulation in kidney transplant recipients: Direct oral anticoagulants versus vitamin-k antagonists},
journal = {European Journal of Internal Medicine},
year = {2024},
volume = {119},
pages = {71--77},
doi = {10.1016/j.ejim.2023.08.003}
}
EUVIMED